Apeloa Pharmaceutical Co. Ltd.   Report issue

For profit Phase 2
Founded: zhejiang China (2003)

Organization Overview

First Clinical Trial
2017
NCT04486430
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Zhejiang Apeloa Jiayuan Pharmaceutical Co. Ltd.

Active Ingredients

Drugs in Phase 2 Trials (1)

neu2000kwl (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cerebral Infarction (Phase 2)

Infarction (Phase 2)

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1